Unichem Laboratories share price

Balanced risk
  • 40%Low risk
  • 40%Moderate risk
  • 40%Balanced risk
  • 40%High risk
  • 40%Extreme risk
  • ₹616.10(-0.56%)
    April 28, 2025 15:28:02 PM IST
    • NSE
    • BSE
  • Vol : 17.11K (NSE + BSE)
    Last 20 day avg : 76.54 K

Unichem Laboratories is trading -0.56% lower at Rs 616.10 as compared to its last closing price. Unichem Laboratories has been trading in the price range of 626.35 & 613.20. Unichem Laboratories has given -17.02% in this year & 0.52% in the last 5 days. The company posted a net profit of 57.85 Crores in its last quarter.Listed peers of Unichem Laboratories include Pfizer (0.51%), Neuland Laboratories (2.20%), Unichem Laboratories (-0.56%).The Mutual Fund holding in Unichem Laboratories was at 9.89% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Unichem Laboratories was at 0.98% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 28, 2025, 01:18 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.84
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.84
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.10
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
613.20
Highest
626.35
52 week range
Lowest
507.20
Highest
949.85
Unichem Laboratories News
Unichem Laboratories Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 22.72% from Rs 533.09 crore to Rs 434.38 crore, year-on-year
    • financial-insightsThe company's profit declined by 31.12% year-on-year during the December quarter, dropping from Rs 83.99 crore to Rs 57.85 crore
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Unichem Laboratories Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 751.53
  • R2
  • 810.27
  • R3
  • 910.53
Pivot651.27
  • S1
  • 592.53
  • S2
  • 492.27
  • S3
  • 433.53
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Unichem Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Pfizer
Neutral
4,267.900.5119,526.0535.495.410.821.51
Neuland Laboratories
Neutral
12,570.652.2016,064.7949.5712.30.114.22
Unichem Laboratories
Bearish
616.10-0.564,379.40-1.84-2.64
Jagsonpal Pharmaceuticals
Bullish
233.20-4.251,548.4271.138.50.834.03
Themis Medicare
Bearish
131.30-1.501,215.7828.293.250.377.09
Unichem Laboratories Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Unichem Laboratories is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 70.22%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.07 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.31 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    DSP Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 58.81
    • % of AUM 1.95
    HDFC Small Cap Fund Growth
    3/5
    • Amount Invested (Cr.) 381.43
    • % of AUM 1.26
    Franklin India Opportunities Fund Growth
    NA
    • Amount Invested (Cr.) 23.13
    • % of AUM 0.38
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
    NA
    • Amount Invested (Cr.) 17.16
    • % of AUM 0.35
    Quant Value Fund Regular Growth
    3/5
    • Amount Invested (Cr.) 4.27
    • % of AUM 0.25
    Unichem Laboratories Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-02-06Quarterly Results
    2024-11-13Quarterly Results
    2024-09-30Others
    2024-08-08Quarterly Results
    2024-05-22Audited Results
    About the company Unichem Laboratories
    • IndustryMajor Drugs
    • ISININE351A01035
    • BSE Code506690
    • NSE CodeUNICHEMLAB
    Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
    • Management Info
    • Pradeep BhandariChief Compliance Officer, Company Secretary
    • Pabitrakumar BhattacharyyaManaging Director, Additional Director
    Unichem Laboratories Share Price FAQs

    Unichem Laboratories is trading at 616.10 as on Mon Apr 28 2025 09:58:02. This is -0.56% lower as compared to its previous closing price of 619.60.

    The market capitalization of Unichem Laboratories is 4379.40 Cr as on Mon Apr 28 2025 09:58:02.

    The 52 wk high for Unichem Laboratories is 949.85 whereas the 52 wk low is 507.20

    Unichem Laboratories can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 26.62
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Unichem Laboratories reported a net profit of -70.47 Cr in 2024.

    The Mutual Fund Shareholding was 9.89% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Unichem Laboratories QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Unichem Laboratories share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.